- Home
- XNCR vs NXJ Comparison
XNCR vs NXJ Comparison
Compare XNCR & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- NXJ
- Stock Information
- Founded
- XNCR 1997
- NXJ 1999
- Country
- XNCR United States
- NXJ United States
- Employees
- XNCR N/A
- NXJ N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- NXJ Finance/Investors Services
- Sector
- XNCR Health Care
- NXJ Finance
- Exchange
- XNCR Nasdaq
- NXJ Nasdaq
- Market Cap
- XNCR 565.1M
- NXJ 457.7M
- IPO Year
- XNCR 2013
- NXJ N/A
- Fundamental
- Price
- XNCR $8.73
- NXJ $11.14
- Analyst Decision
- XNCR Buy
- NXJ
- Analyst Count
- XNCR 7
- NXJ 0
- Target Price
- XNCR $27.50
- NXJ N/A
- AVG Volume (30 Days)
- XNCR 540.9K
- NXJ 74.9K
- Earning Date
- XNCR 08-08-2025
- NXJ 01-01-0001
- Dividend Yield
- XNCR N/A
- NXJ 3.27%
- EPS Growth
- XNCR N/A
- NXJ N/A
- EPS
- XNCR N/A
- NXJ N/A
- Revenue
- XNCR $127,228,000.00
- NXJ N/A
- Revenue This Year
- XNCR N/A
- NXJ N/A
- Revenue Next Year
- XNCR $28.84
- NXJ N/A
- P/E Ratio
- XNCR N/A
- NXJ N/A
- Revenue Growth
- XNCR N/A
- NXJ N/A
- 52 Week Low
- XNCR $7.16
- NXJ $10.06
- 52 Week High
- XNCR $27.24
- NXJ $12.24
- Technical
- Relative Strength Index (RSI)
- XNCR 47.62
- NXJ 40.09
- Support Level
- XNCR $9.00
- NXJ $11.06
- Resistance Level
- XNCR $9.45
- NXJ $11.46
- Average True Range (ATR)
- XNCR 0.45
- NXJ 0.09
- MACD
- XNCR -0.01
- NXJ -0.01
- Stochastic Oscillator
- XNCR 21.76
- NXJ 20.00
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.